Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes

被引：0
|
作者：
Kim, Kyoung Min
Lee, Seo Young
Lee, Ji Hyun
Lee, Dong Hwa
Oh, Tae Jung
Jang, Hak Chul
Lim, Soo
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1290-P
引用
收藏
页码：A346 / A346
页数：1
相关论文
共 50 条
  • [1] Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naive patients with type 2 diabetes: initial triple study
    Lim, Soo
    Ku, Eu Jeong
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Jie-Eun
    Kim, Kyoung Min
    Davies, Melanie J.
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
  • [2] Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects
    Lim, Soo
    Sohn, Minji
    Shin, Yujin
    Ferrannini, Ele
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (04): : 757 - 762
  • [3] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Liu, G.
    Lee, M. A.
    Sisk, C. McCrary
    Williams-Herman, D. E.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETOLOGIA, 2010, 53
  • [4] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Lee, M. A.
    Sisk, C. M.
    Williams-Herman, D. E.
    Engel, S. S.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (09) : 930 - 938
  • [5] Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes
    Lim, S.
    Min, K.
    Yu, J. -M.
    Chamnan, P.
    Kim, E.
    Yoon, K. -H.
    Kwon, S.
    Moon, M.
    Lee, K.
    Kim, D. -J.
    Kim, M.
    Wongtanate, M.
    Kim, E.
    Kim, S. -H.
    Lee, M. -K.
    [J]. DIABETOLOGIA, 2015, 58 : S54 - S54
  • [6] Efficacy of initial triple combination therapy with metformin, dapagliflozin and saxagliptin in drug-naive patients with type 2 diabetes: a randomised controlled trial
    Kim, N.
    Kim, J.
    Moon, J.
    Lee, Y. -H.
    Kim, T.
    Cho, H.
    Kwak, S.
    Lim, S.
    Kim, D.
    Moon, M.
    Kim, S.
    [J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S151 - S151
  • [7] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    [J]. DIABETOLOGIA, 2015, 58 : S388 - S388
  • [8] Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Mu, Yiming
    Pan, Changyu
    Fan, Bei
    Hehnke, Uwe
    Zhang, Xiuzhen
    Zhang, Xuejun
    Wang, Xiaoyue
    Liu, Jingdong
    Zhang, Ying
    Du, Jianling
    Ma, Jianhua
    Gong, Yan
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 48 - 56
  • [9] EFFECTS OF GEMIGLIPTIN VERSUS SITAGLIPTIN OR GLIMEPIRIDE ON GLYCEMIC VARIABILITY AS INITIAL COMBINATION THERAPY WITH METFORMIN IN DRUG-NAIVE PATIENTS WITH TYPE 2 DIABETES
    Park, S. E.
    Lee, B. -W.
    Kim, J. H.
    Jung, C. H.
    Lee, S. -H.
    Suh, S. H.
    Lee, W. J.
    Jang, Y. H.
    Kim, S. -H.
    Park, C. -Y.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S139 - S139
  • [10] Effects of gemigliptin versus sitagliptin or glimepiride on glycaemic variability as initial combination therapy with metformin in drug-naive patients with type 2 diabetes
    Lee, B. -W.
    Kim, J.
    Park, S.
    Jung, C.
    Lee, S. -H.
    Suh, S.
    Lee, W.
    Cho, J. -H.
    Jang, Y.
    Kim, S. -H.
    Park, C. -Y.
    [J]. DIABETOLOGIA, 2015, 58 : S387 - S387
12345